Scientific Opinion on the substantiation of health claims related to chitosan and reduction in body weight (ID 679, 1499), maintenance of normal blood LDL-cholesterol concentrations (ID 4663), reduction of intestinal transit time (ID 4664) and reduction o
Open Access
- 30 June 2011
- journal article
- opinion
- Published by Wiley in EFSA Journal
- Vol. 9 (6)
- https://doi.org/10.2903/j.efsa.2011.2214
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Evaluating efficacy of a chitosan product using a double-blinded, placebo-controlled protocol.Journal of the American College of Nutrition, 2006
- Chitosan for overweight or obesityPublished by Wiley ,2005
- The effect of the dietary supplement, Chitosan, on body weight: a randomised controlled trial in 250 overweight and obese adultsInternational Journal of Obesity, 2004
- Effects of a Stimulant-Free Dietary Supplement on Body Weight and Fat Loss in Obese Adults: A Six-Week Exploratory StudyCurrent Therapeutic Research, 2003
- Comparative Evaluation of Fecal Fat Excretion Induced by Orlistat and ChitosanObesity Research, 2001
- Randomized, double-blind trial of chitosan for body weight reductionEuropean Journal of Clinical Nutrition, 1999
- Decrease in serum LDL cholesterol with microcrystalline chitosanMethods and Findings in Experimental and Clinical Pharmacology, 1999
- A Double-blind, Placebo-controlled Evaluation of the Effects of RW94 on the Body Weight of Both Overweight and Obese Healthy VolunteersCurrent Medical Research and Opinion, 1998
- Effect of the Viscosity or Deacetylation Degree of Chitosan on Fecal Fat Excreted from Rats Fed on a High-fat DietBioscience, Biotechnology, and Biochemistry, 1995
- A novel use of chitosan as a hypocholesterolemic agent in ratsThe American Journal of Clinical Nutrition, 1980